Notice of NHLBI Discontinuation of Grant Program "Ancillary Studies in Clinical Trials (R01)"

Notice Number: NOT-HL-14-232

Key Dates
Release Date: July 29, 2014

Related Announcements

RFA-HL-13-003
RFA-HL-14-004

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

This Notice informs potential applicants that NHLBI has discontinued the grant program for Ancillary Studies in Clinical Trials.  The most recent FOA for this program RFA-HL-14-004 "Ancillary Studies in Clinical Trials (R01)" expired on May 24, 2014, and will not be reissued. 

In the future, applicants have the opportunity to submit ancillary studies to NHLBI via PA-13-302 "Research Project Grant (Parent R01)."

Inquiries

Please direct all inquiries to:

Abby Ershow, Sc.D.
National Heart, Lung, and Blood Institute
Telephone: 301-435-0550
Email: Abby.Ershow@nih.gov